Google's NotebookLM rolled out two more features this week, allowing you to generate educational videos or pre-made documents ...
ReNerve has expanded the ongoing clinical study evaluating its flagship NervAlign nerve cuff, following encouraging interim results.
Google outlines how Gemini, NotebookLM and Search are reshaping how students learn, blending curiosity, creativity and AI-driven insight.
Edvoy, India's leading student recruitment platform, will host the UK and Ireland Admissions Day on Saturday, 8 November 2025 ...
With bountiful organic produce, sustainable wineries and a glorious Pacific coastline, Sonoma county in northern California ...
US Weekly on MSN
Alex Rodriguez’s Kids Guide: All About the New York Yankees Legend’s 2 Daughters Natasha and Ella
New York Yankees legend Alex Rodriguez has two daughters, Natasha and Ella, from his 6-year marriage to Cynthia Scurtis ...
Be on the lookout for kids in dark costumes in streets and sidewalks, and stay off of the road if you can. Parents and children should be aware of their surroundings while trick-or-treating. Children ...
Youth, women to lead Tanzania’s mechanization revolution, govt' announces major equipment allocation
Tanzania’s push to modernize its agricultural sector took a significant step forward today as key national stakeholders ...
AllAfrica on MSN
Mwanza Border Post Time Release Study Report Launched to Enhance Trade Efficiency and Regional Integration
The Southern African Development Community (SADC), facilitated the official launch of the Time Release Study (TRS) Report for the Mwanza/Zobue Border Post on 11 November 2025 in Lilongwe, Republic of ...
Tiny viruses that only infect and kill bacteria can help treat deadly antibiotic-resistant bloodstream infections with Staphylococcus aureus, results from a mid-stage trial suggest.
Waterberg TVET College is a reputable government institution that offers practical and theoretical educational methods. The ...
Stockhead on MSN
Alterity delivers encouraging phase II data in MSA trial
Alterity Therapeutics’ phase II study of its lead compound ATH434 in multiple system atrophy (MSA) has been featured in an oral presentation at the American Autonomic Society (AAS) 36th International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results